XCUR
XCUR
NASDAQ · Biotechnology

Exicure Inc

$4.03
-0.23 (-5.40%)
As of Feb 8, 2:21 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 10.40M 9.97M 8.09M
Net Income 1.68M 1.79M 1.56M
EPS
Profit Margin 16.1% 17.9% 19.2%
Rev Growth +2.0% -1.5% -6.8%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 7.74M 7.83M 6.95M
Total Equity 23.39M 23.00M 25.54M
D/E Ratio 0.33 0.34 0.27
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 3.32M 3.17M 2.28M
Free Cash Flow 838.7K 1.16M 856.1K